28.75
price up icon1.66%   0.47
after-market Handel nachbörslich: 28.75
loading
Schlusskurs vom Vortag:
$28.28
Offen:
$28.34
24-Stunden-Volumen:
87,453
Relative Volume:
0.47
Marktkapitalisierung:
$844.28M
Einnahmen:
$4.12M
Nettoeinkommen (Verlust:
$-56.68M
KGV:
-
EPS:
-
Netto-Cashflow:
$-51.44M
1W Leistung:
+3.60%
1M Leistung:
+2.68%
6M Leistung:
+11.43%
1J Leistung:
+139.58%
1-Tages-Spanne:
Value
$28.14
$29.19
1-Wochen-Bereich:
Value
$27.41
$29.19
52-Wochen-Spanne:
Value
$6.58
$33.77

Dianthus Therapeutics Inc Stock (DNTH) Company Profile

Name
Firmenname
Dianthus Therapeutics Inc
Name
Telefon
857-201-2700
Name
Adresse
300 TECHNOLOGY SQUARE, CAMBRIDGE
Name
Mitarbeiter
53
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
DNTH's Discussions on Twitter

Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-26 Eingeleitet Robert W. Baird Outperform
2024-06-27 Eingeleitet Cantor Fitzgerald Overweight
2024-05-16 Eingeleitet H.C. Wainwright Buy
2024-02-15 Eingeleitet Stifel Buy
2023-12-26 Eingeleitet Jefferies Buy
2023-11-22 Eingeleitet Wedbush Outperform
2023-10-30 Eingeleitet Guggenheim Buy
2023-09-28 Eingeleitet Raymond James Outperform
2022-08-25 Herabstufung Goldman Buy → Neutral
2022-01-06 Hochstufung Goldman Neutral → Buy
2021-08-20 Fortgesetzt Goldman Neutral
2021-08-03 Herabstufung JP Morgan Overweight → Neutral
2021-07-22 Bestätigt B. Riley Securities Buy
2021-06-29 Eingeleitet Cantor Fitzgerald Overweight
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-18 Eingeleitet B. Riley Securities Buy
2021-01-07 Eingeleitet Mizuho Buy
2020-06-08 Hochstufung Goldman Neutral → Buy
2019-03-25 Herabstufung Goldman Buy → Neutral
2019-03-15 Eingeleitet Raymond James Outperform
Alle ansehen

Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten

pulisher
Nov 04, 2024

Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Oct 23, 2024

Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

SG Americas Securities LLC Increases Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Oct 22, 2024
pulisher
Oct 15, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 5%Should You Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting - The Manila Times

Oct 15, 2024
pulisher
Oct 14, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.4%Here's What Happened - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives $45.13 Consensus Target Price from Brokerages - MarketBeat

Oct 13, 2024
pulisher
Oct 09, 2024

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.7% Jump Turn into More Strength? - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 4.5% – Still a Buy? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 4.5%Should You Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Dianthus: Modest Opportunity With 2 Caveats (NASDAQ:DNTH) - Seeking Alpha

Oct 08, 2024
pulisher
Oct 07, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 5.7%Here's Why - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading Volume – Still a Buy? - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Marshall Wace LLP Sells 4,731 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Dianthus started at outperform by Oppenheimer on DNTH103 opportunity - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

Dianthus started at outperform by Oppenheimer on DNTH103 opportunity (NASDAQ:DNTH) - Seeking Alpha

Oct 03, 2024
pulisher
Oct 03, 2024

Oppenheimer Initiates Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap Down to $27.88 - Defense World

Oct 02, 2024
pulisher
Oct 02, 2024

Renaissance Technologies LLC Lowers Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Oct 02, 2024
pulisher
Oct 02, 2024

American Century Companies Inc. Increases Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Oct 02, 2024
pulisher
Sep 28, 2024

Fred Alger Management LLC Has $163,000 Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Rating Reiterated by HC Wainwright - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Expert Ratings For Dianthus Therapeutics - Benzinga

Sep 26, 2024
pulisher
Sep 25, 2024

Point72 Asia Singapore Pte. Ltd. Acquires 29,159 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Point72 Asia Singapore Pte. Ltd. Has $1.02 Million Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) Director Sells 40,831 Shares of Stock - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Dirk Kersten Sells 79,411 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Logos Global Management LP Sells 1,465,000 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Dyne Therapeutics (NASDAQ:DYN) Shares Down 3% - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Holdings Boosted by Great Point Partners LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Dianthus Therapeutics (NASDAQ:DNTH) and Oramed Pharmaceuticals (NASDAQ:ORMP) Financial Review - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Thrivent Financial for Lutherans - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Boosts Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Rhumbline Advisers Acquires Shares of 32,138 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Dropbox CEO Andrew Houston sells shares worth over $87,000 - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 3.2% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

How does Dianthus Therapeutics Inc (DNTH) change from a tortoise to a hare? - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Dyne Therapeutics’ (DYN) “Overweight” Rating Reaffirmed at Piper Sandler - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Incyte Insiders Sold US$4.8m Of Shares Suggesting Hesitancy - Simply Wall St

Sep 23, 2024
pulisher
Sep 22, 2024

Victory Capital Management Inc. Takes Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 7.5% - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

31,047 Shares in Incyte Co. (NASDAQ:INCY) Purchased by XTX Topco Ltd - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Trading 7.5% Higher - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 5.3% - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

WINTON GROUP Ltd Buys Shares of 10,238 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - Kilgore News Herald

Sep 18, 2024
pulisher
Sep 18, 2024

Dyne Therapeutics director sells over $161k in company stock - Investing.com India

Sep 18, 2024
pulisher
Sep 18, 2024

Dyne Therapeutics Inc (DYN) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 18, 2024

Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):